Sangamo Therapeutics (NASDAQ:SGMO) PT Lowered to $3.00 at HC Wainwright
Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its target price trimmed by HC Wainwright from $5.00 to $3.00 in a report published on Monday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q4 2023 earnings at ($0.24) EPS, FY2023 earnings at […]
More Stories
iPhone 17, Air, Pro, and Pro Max: Expected Launch Date, Price, Updated Features
Are you also waiting to upgrade your iPhone, or want to make a purchase? So, this article is for you. ...
Modera Wealth Management LLC Acquires 2,024 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Modera Wealth Management LLC lifted its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.1% in the 1st quarter,...
Seizert Capital Partners LLC Reduces Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Seizert Capital Partners LLC decreased its holdings in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.2% during the 1st quarter,...
Howard Capital Management Inc. Sells 9,449 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Howard Capital Management Inc. lessened its position in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 5.3% during the...
Mesirow Financial Investment Management Inc. Has $61.76 Million Stock Position in Alphabet Inc. (NASDAQ:GOOGL)
Mesirow Financial Investment Management Inc. lessened its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.8% in the 1st...
North Star Asset Management Inc. Sells 191 Shares of Alphabet Inc. (NASDAQ:GOOGL)
North Star Asset Management Inc. decreased its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 0.3% during...